Preliminary studies on Alzheimer's disease using cDNA microarrays

Mechanisms of Ageing and Development

Volumn 124, Issue 1, 2003, Pages 115-124

  Wang, Guoqing ^a,b   Zhang, Yan ^a,b   Chen, Biao ^d   Cheng, Jing ^a,b,c  

^a TSINGHUA UNIVERSITY   (China)

^b National Engineering Research Center for Beijing Biochip Technology   (China)

^c Capital Biochip Corporation   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; C terminal binding protein 1; cDNA microarray; Transforming growth factor

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; GENE PRODUCT; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; CASE REPORT; CONFERENCE PAPER; DNA MICROARRAY; FETUS; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; PRIORITY JOURNAL;

EID: 0037285379     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(02)00188-4     Document Type: Conference Paper

References (22)

1. Shastry B.S., Giblin F.J. Genes and susceptible loci of Alzheimer's disease. Brain Res. Bull. 48:(2):1999;121-127.
2. Boyd J.M., Subramanian T., Schaeper U., La Regina M., Bayley S., Chinnadurai G. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12:1993;469-478.
3. De Servi B., La Porta C.A., Bontempelli M., Comolli R. Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. Exp. Gerontol. 37:(6):2002;813-821.
4. DeRisi J., Penland L., Brown P.O., Bittner M.L., Meltzer P.S., Ray M., Chen Y., Su Y.A., Trent J.M. Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat. Genet. 14:1997;457-460.
5. Fields S., Kohara Y., Lockhart D.J. Functional genomics. Proc. Natl. Acad. Sci. USA. 96:1996;8825-8826.
6. Goffeau A., Barrell B.G., Bussey H., Davis R.W., Dujon B., Feldmann H., Galibert F., Hoheisel J.D., Jacq C., Johnston M., Louis E.J., Mewes H.W., Murakami Y., Philippsen P., Tettelin H., Oliver S.G. Life with 6000 genes. Science. 274:1996;563-567.
7. Goldschmidt-Clermont P.J., Furman M.I., Wachsstock D., Safer D., Nachmias V.T., Pollard T.D. The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells. Mol. Biol. Cell. 3:(9):1992;1015-1024.
8. Heizmann C.W., Fritz G., Schafer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 7:2002;1356-1368.
9. Izutsu K., Kurokawa M., Imai Y., Maki K., Mitani K., Hirai H. The corepressor CTBP interacts with Evi-1 to repress transforming growth factor signaling. Blood. 97:(9):2001;2815-2822.
10. Lesne S., Blanchet S., Docagne F., Liot G., Plawinski L., MacKenzie E.T., Auffray C., Buisson A., Pietu G., Vivien D. Transforming growth factor-beta1-modulated cerebral gene expression. J. Cereb. Blood Flow Metab. 22:(9):2002;1114-1123.
11. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., Mittmann M., Wang C., Kobayashi M., Horton H., Brown E.L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14:1996;1675-1678.
12. Mahlapuu M., Enerback S., Carlsson P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development. 128:(12):2001;2397-2406.
13. Masliah E., Ho G., Wyss-Coray T. Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice. Neurochem. Int. 39:(5-6):2001;393-400.
14. Nibu Y., Zhang H., Levine M. Interaction of short-range repressors with Drosophila CtBP in the embryo. Science. 280:1998;101-104.
15. Palu E., Liesi P.J. Differential distribution of laminins in Alzheimer disease and normal human brain tissue. Neurosci. Res. 69:(2):2002;243-256.
16. Pasinetti G.M., Ho L. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia. Restor. Neurol. Neurosci. 18:(2-3):2001;137-142.
17. Schaeper U., Boyd J.M., Verma S., Uhlmann E., Subramanian T., Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA. 92:1995;10467-10471.
18. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
19. Southern E., Mir K., Shchepinov M. Molecular interactions on microarrays. Nat. Genet. 21:1999;5-9.
20. Tsuji T., Shimohama S. Analysis of the proteomic profiling of brain tissue in Alzheimer's disease. Dis. Markers. 17:(4):2001;247-257.
21. Witke W., James D., Sutherland, Sharpe A., Arai M., David J., Kwiatkowski. Profilin I is essential for cell survival and cell division in early mouse development. Proc. Natl. Acad. Sci. USA. 98:2001;3832-3836.
22. Xie M.J., Motoo Y., Su S.B., Mouri H., Ohtsubo K., Matsubara F., Sawabu N. Expression of clusterin in human pancreatic cancer. Pancreas. 25:(3):2002;234-238.